Brief: China Biotech Services Says Unit Entered Agreement Relating To Candidate Vaccine For COVID-19
29/09/2020 16:18
Sept 29 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* CHINA BIOTECH SERVICES-UNIT ENTERED TECHNOLOGY TRANSFER
AGREEMENT FOR CELL LINES OF GENETICALLY ENGINEERED RECOMBINANT
CANDIDATE VACCINE FOR COVID-19
* CHINA BIOTECH SERVICES-DEAL WITH NATIONAL INSTITUTE FOR
VIRAL
DISEASE CONTROL & PREVENTION, CHINESE CENTER FOR DISEASE CONTROL
& PREVENTION
Source text for Eikon: ID:nHKS5DFWx3
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)